InspireMD wins CE Mark for MGuard blood clot stent

March 15, 2013 by Brad Perriello

InspireMD lands CE Mark approval in the European Union for its MGuard embolic protection stent.

InspireMD

InspireMD (OTC:NSPR) said it won a nod from European regulators for its MGuard embolic protection stent, designed to prevent strokes after carotid artery stenting procedures.

The Tel-Aviv-based medical device company said the MGuard device is wrapped with its MicroNet mesh to prevent embolisms – blood clots – from occurring during and after the placement of a carotid stent.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp